MKT Capital Completes Successful Withhold Campaign at Aurinia Pharmaceuticals

Following a successful withhold campaign by Olshan client MKT Capital, two directors of Aurinia Pharmaceuticals – the Chairman of the Board and the Chairman of the Compensation Committee – tendered their resignations after failing to receive the requisite majority vote. Shareholders also overwhelmingly voted down Aurinia’s say-on-pay proposal and an amendment to its equity incentive plan. MKT Capital launched its withhold campaign in an effort to combat egregious executive compensation practices and instill a sense of accountability in Aurinia’s boardroom.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.